SCHEMBL23791024

SCHEMBL23791024

CC(C)=CCCC(C)C1CCC2(C)C3CCC4C(C)(C)C(OC(=O)/C=C/c5ccccc5)CCC45CC35CCC12C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 2/20 0.57
▸ ACACA Q13085 2/20 0.57
▸ USP2 O75604 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ PTPN11 Q06124 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ CYP2C19 P33261 1/20 0.43
▸ PTGES O14684 2/20 0.43
▸ PTPN2 P17706 1/20 0.41
▸ PTPN1 P18031 1/20 0.41
▸ ACP1 P24666 1/20 0.41
▸ IKBKB O14920 2/20 0.41
▸ HSD11B1 P28845 3/20 0.40
▸ HSD11B2 P80365 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31149054 0.90 ACLY (0.52) ACLYACACAUSP2ALDH1A1CYP3A4
SCHEMBL10049046 0.89 MEN1 (0.53) ACLYACACAUSP2ALDH1A1CYP3A4
Gamma Oryzanol SCHEMBL718726 0.88 MEN1 (0.60) ACLYACACAUSP2ALDH1A1CYP3A4
Gamma Oryzanol SCHEMBL12152368 0.88 MEN1 (0.60) ACLYACACAUSP2ALDH1A1CYP3A4
Gamma Oryzanol SCHEMBL21235210 0.88 MEN1 (0.60) ACLYACACAUSP2ALDH1A1CYP3A4
Gamma Oryzanol SCHEMBL23105398 0.88 MEN1 (0.60) ACLYACACAUSP2ALDH1A1CYP3A4
Gamma Oryzanol SCHEMBL29357024 0.88 MEN1 (0.60) ACLYACACAUSP2ALDH1A1CYP3A4
Gamma Oryzanol SCHEMBL29354302 0.88 MEN1 (0.60) ACLYACACAUSP2ALDH1A1CYP3A4
SCHEMBL23791003 0.87 MEN1 (0.58) ACLYACACAPTPN11MEN1KMT2A
SCHEMBL10017450 0.86 MEN1 (0.51) ACLYACACAUSP2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275939-A1 MARSDENIA CUNDURANGO CREEPER EXTRACTS, COSMETIC COMPOSITIONS COMPRISING THEM AND COSMETIC USES OF SAME ISP INVESTMENTS LLC (US) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275939-A1 MARSDENIA CUNDURANGO CREEPER EXTRACTS, COSMETIC COMPOSITIONS COMPRISING THEM AND COSMETIC USES OF SAME CUTA, TYR, TPSD1 ACLY 932/4885ACACA 490/4885USP2 1744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback